Despite years of warnings and a mountain of scientific evidence linking smoking to lung cancer, there remains one confounding question: Why do some smokers never get lung cancer? It’s a puzzle ...

Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...

Lung cancer becomes advanced when it spreads to the other lung or other parts of your body. Sometimes, it's called metastatic or stage IV disease. There are two main forms: non-small-cell lung ...

ST. PAUL, Minn., May 19 (UPI) --With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting the promise of an artificial intelligence ...

Lung cancer has been and continues to be a major cause of death in both men and women in the United States and around the world. The causal relationship between tobacco and lung cancer was first ...

Scientists may have discovered why lifelong smokers never get lung cancer. That sentence probably seems silly, especially given that cigarettes are the number one risk factor for lung cancer.

Which of these comments is not like the others? Learn how to support someone with lung cancer. It can be hard to find the right words when someone you know and love tells you they’ve been ...

ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage in most patients treated. The United States Food and Drug Administration ...

Exposure to wildfire smoke may increase lung cancer patients' risk of dying from their disease, particularly among non-smokers, but the effect may be mitigated by certain cancer treatments ...

New robotic technology has arrived at Puyallup’s MultiCare Good Samaritan Hospital – and it creates a world of difference for lung cancer patients in Pierce County. The DaVinci ION robotic ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. But the pair’s success leaves room for improvement for future ...